Sperm Is a Focus of Start-Ups Looking to Boost Fertility
By Fiorella Valdesolo,
WSJ Magazine
| 06. 08. 2022
“Where is the we?” It’s the question that was the driving force for Vida Delrahim and Ronit Menashe when they created WeNatal, a new brand of prenatal supplements that aims to be more inclusive. In the process of trying to conceive, couples often use the word we. We’re trying to get pregnant. We’re having trouble conceiving. We’re having a baby. But, as Delrahim and Menashe realized after their own individual struggles to conceive, despite all the we, much of the burden of fertility optimization continues to fall on women. It’s an imbalance that WeNatal and a number of other start-ups are starting to address.
In the quest for high-quality embryos and viable pregnancies, sperm is critical, says Toronto-based reproductive endocrinologist Dan Nayot, who is chief medical advisor for fertility supplement company Bird&Be. And good sperm is about both quality and quantity. In a routine semen analysis, Nayot generally looks at the volume of semen (a combination of seminal fluid and sperm); sperm concentration (how many millions of sperm per millimeter); sperm motility (how many are actually moving...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...